These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36512296)

  • 1. Albuminuria as a biomarker of severity in diabetic retinopathy and in the response to intravitreal treatment in diabetic macular edema.
    Gibelalde A; Amenabar Alonso A; Pinar-Sueiro S; Bilbao-Garay I; Juaristi Eizmendi L; Sampedro A
    Int Ophthalmol; 2023 Jun; 43(6):2049-2056. PubMed ID: 36512296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Estimated Glomerular Filtration Rate With Diabetic Retinopathy and Macular Edema.
    Man RE; Sasongko MB; Wang JJ; MacIsaac R; Wong TY; Sabanayagam C; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4810-6. PubMed ID: 26218909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Younger Age and Albuminuria are Associated with Proliferative Diabetic Retinopathy and Diabetic Macular Edema in the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) Study.
    Susarla G; Rizza AN; Li A; Han S; Khan R; Chan W; Lains I; Apivatthakakul A; Brustoski K; Khetan V; Raman R; Igo RP; Iyengar SK; Mathavan S; Sobrin L
    Curr Eye Res; 2022 Oct; 47(10):1389-1396. PubMed ID: 35815717
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study.
    Zhuang X; Cao D; Yang D; Zeng Y; Yu H; Wang J; Kuang J; Xie J; Zhang S; Zhang L
    BMJ Open; 2019 Sep; 9(9):e031194. PubMed ID: 31494622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.
    Hsieh YT; Tsai MJ; Tu ST; Hsieh MC
    JAMA Ophthalmol; 2018 Jan; 136(1):68-74. PubMed ID: 29167896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do serum vitamin D levels correlate with Macular Edema or with Diabetic Retinopathy?
    Seyyar SA; Tokuc EO; Tıskaoğlu NS; Karabaş VL; Güngör K
    Eur J Ophthalmol; 2022 Nov; 32(6):3592-3598. PubMed ID: 35088606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Plasma Semaphorin 3A With Phenotypes of Diabetic Retinopathy and Nephropathy.
    Kwon SH; Shin JP; Kim IT; Park DH
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):2983-9. PubMed ID: 27273597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial.
    Maturi RK; Glassman AR; Josic K; Antoszyk AN; Blodi BA; Jampol LM; Marcus DM; Martin DF; Melia M; Salehi-Had H; Stockdale CR; Punjabi OS; Sun JK;
    JAMA Ophthalmol; 2021 Jul; 139(7):701-712. PubMed ID: 33784735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
    Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
    Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with follow-up in patients with diabetic macular edema: Eye care center vs. diabetes care center.
    Kumar G; Velu S; Rajalakshmi R; Surya J; Mohan V; Raman A; Raman R
    Indian J Ophthalmol; 2023 Jun; 71(6):2531-2536. PubMed ID: 37322675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of estimated glomerular filtration rate on diabetic macular edema.
    Temkar S; Karuppaiah N; Takkar B; Bhowmik D; Tripathi M; Ramakrishnan S; Sharma YR; Vohra R; Chawla R; Venkatesh P
    Int Ophthalmol; 2018 Jun; 38(3):1043-1050. PubMed ID: 28523527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and Risk Factors for Diabetic Retinopathy and Diabetic Macular Edema in Patients with Early- and Late-Onset Diabetes Mellitus.
    Wang Y; Lin Z; Zhai G; Ding XX; Wen L; Li D; Zou B; Feng KM; Liang YB; Xie C
    Ophthalmic Res; 2022; 65(3):293-299. PubMed ID: 32353847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-VEGF therapy for diabetic retinopathy].
    Chekhonin ES; Fayzrakhmanov RR; Sukhanova AV; Bosov ED
    Vestn Oftalmol; 2021; 137(4):136-142. PubMed ID: 34410069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study.
    Wirkkala J; Kubin AM; Ohtonen P; Yliselä J; Siik T; Hautala N
    BMC Ophthalmol; 2022 Jun; 22(1):258. PubMed ID: 35681133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severity of diabetic macular edema (DME) in Seine St Denis among patients treated by anti-VEGF].
    Stéphan S; Fajnkuchen F; Addou-Regnard M; Grenet T; Nghiem-Buffet S; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2014 Nov; 37(9):717-21. PubMed ID: 25308789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF-A gene polymorphisms and responses to intravitreal ranibizumab treatment in patients with diabetic macular edema.
    Tetikoğlu M; Yüksel Z; Aktas S; Sağdik HM; Özcura F
    Int Ophthalmol; 2018 Dec; 38(6):2381-2388. PubMed ID: 29030794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current intravitreal pharmacologic therapies for diabetic macular edema.
    Colucciello M
    Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.